The Parkinson’s Basis publishes outcomes of the primary survey on medical hashish and Parkinson’s

The Parkinson’s Foundation today announced the results of its medical cannabis and Parkinson’s (PD) survey. The survey, titled “Weeding Through the Haze: A Survey of Cannabis Use Among People With Parkinson’s Disease in the US,” was distributed to 7,607 people with Parkinson’s disease in January 2020, analyzing 1,064 complete responses.

The survey asked specific questions about cannabis use – from symptom management to motivation to use to side effects – and questions for those who don’t use cannabis and why. 25 percent of those surveyed had used cannabis in the past six months and less than 13 percent of consumers reported negative side effects of cannabis use. More than half of the respondents found out about cannabis use on the Internet or from friends or other people with Parkinson’s.

“At a time when cannabis is legal in more states than ever before, we believe this survey will provide new and important information for the growing population of cannabis users with Parkinson’s disease,” said James Beck, PhD, senior vice president and Chief Scientific Officer of the Parkinson’s Foundation. “Ultimately, our goal is to achieve better outcomes for all people with Parkinson’s disease, and we are committed to addressing issues that are a priority for the PD community.”

– Read the entire article on PR News Wire.

Comments are closed.